Broad-Spectrum Inhibition of HIV-1 by a Monoclonal Antibody
Author Information
Author(s): Burastero Samuele E., Frigerio Barbara, Lopalco Lucia, Sironi Francesca, Breda Daniela, Longhi Renato, Scarlatti Gabriella, Canevari Silvana, Figini Mariangela, Lusso Paolo
Primary Institution: San Raffaele Scientific Institute, Milan, Italy
Hypothesis
Can a monoclonal antibody directed against a gp120-induced epitope of CD4 provide broad-spectrum inhibition of HIV-1?
Conclusion
The study found that the monoclonal antibody DB81 effectively inhibits HIV-1 without suppressing T-cell activation.
Supporting Evidence
- Immunization with HIV-1 envelope complexes led to the production of antibodies that inhibited HIV-1.
- MAb DB81 showed broad HIV-1 inhibitory activity without suppressing T-cell activation.
- DB81 preferentially binds to a complex-enhanced epitope on CD4.
Takeaway
Scientists created a special antibody that can stop HIV from infecting cells, and it doesn't make the immune system weaker.
Methodology
Mice were immunized with HIV-1 envelope complexes, and their sera were tested for HIV-1 inhibition and antibody binding.
Potential Biases
The study may have bias due to the use of a specific mouse model and the potential for immune responses to differ in humans.
Limitations
The study noted the potential for autoimmune reactions due to anti-human CD4 antibodies and challenges in standardizing immunogen preparations.
Participant Demographics
Balb/c mice were used for immunization.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website